Monthly Archives: January 2017

Double Diaphragm Pumps Market is Expected to Grow at a CAGR of 4.9% by 2027

Global Double Diaphragm Pumps Market Information by Mechanism (Air Operated and Electrically operated.), by operation (Single acting and double acting), by end users Forecast to 2027

Pune, India – January 30, 2017 /MarketersMedia/

Market Research Future published a half cooked research report on Double Diaphragm Pumps Market. The global double diaphragm pumps market is expected to grow over the CAGR of 4.9% during the period 2016 to 2027.

Market Scenario:
A positive displacement pump which utilizes a combination of reciprocating action of a Teflon diaphragm, rubber and valves on either side of the diaphragm is a diaphragm pump. The double diaphragm pumps market is expected to register a CAGR of 4.9%. Recent development in water-wastewater treatment and sanitation has resulted in a significant growth in the Double Diaphragm pumps market. Additionally increased application in the chemical industry is also pushing the demand in the double diaphragm pumps market.

Request a Sample Copy @ https://www.marketresearchfuture.com/sample_request/887

Segments:
The double diaphragm pumps market can be segmented:
On the basis of end users: Water Treatment, Pharmaceuticals, Chemicals, Oil and Gas, Food and Beverage.
On the basis of operation it can be segmented as: Single acting and double acting.
On the basis of Mechanism it can be segmented as: Air Operated and Electrically operated.

Key Players of Double Diaphragm Pumps Market:
• TAPFLO AB
• Leak-Proof Pumps LEWA GmbH
• Verder International B.V.
• Ingersoll-Rand plc
• Pump Solutions Group
• IDEX Corporation,
• Yamada Corporation
• Flowserve Corporation
• Grundfos Holding A/S
• Xylem, Inc.

Access Report Details @ https://www.marketresearchfuture.com/reports/double-diaphragm-pumps-market

Study Objectives of Double Diaphragm Pumps:
• To provide detailed analysis of the market structure along with forecast for the next 10 years of the various segments and sub-segments of the global Double Diaphragm Pumps market.
• To provide insights about factors affecting the market growth.
• To Analyze the Double Diaphragm Pumps market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.
• To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- North America, Europe, Asia, and Rest of the World (ROW).
• To provide country level analysis of the market with respect to the current market size and future prospective.
• To provide country level analysis of the market for segment by Type, Application, Products and its sub-segments.
• To provide strategic profiling of key players in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market.
• To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global Double Diaphragm Pumps market.

Regional Analysis:
Asia pacific is a prominent region for the Double Diaphragm Pumps Market. The Asia pacific is expected to grow at a rapid pace during the forecasted period. Europe and North America are other significant region for this segment because of the favourable development policies.

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact Info:
Name: Akash Anand
Organization: Market Research Future
Address: Hadapsar, Pune
Phone: +1 646 845 9312

Source URL: http://marketersmedia.com/double-diaphragm-pumps-market-is-expected-to-grow-at-a-cagr-of-4-9-by-2027/165404

For more information, please visit https://www.marketresearchfuture.com/

Source: MarketersMedia

Release ID: 165404

Global User Interface Services Market Industry Key Players, Share, Trend, Applications, Segment and Forecast to 2027

User Interface Services Market including Classification, Application and Industry Chain Overview, User Interface Services Market Analysis and Forecast by Product, Type and Region | User Interface Services Market

Pune, India – January 30, 2017 /MarketersMedia/

Market Highlights
The major growth driver of User Interface Services Market includes growing digital technology, increasing market of smartphones and tablets, and growing demand for data monitoring and controlling application in automotive industries among others.

However, lack of expertise and high initial cost is one of the major factors which are hindering the growth of User Interface Services Market.

Industry News
ARM Ltd. has announced in May 2016 about its acquisition of Apical Ltd. which is a global leader in Imaging and computer embedded vision. The acquisition is done to accelerate growth of connected vehicles, smartphones, cameras and other product portfolio.
Apple has announced about its partnership with SAP on May 2016. The partnership is done to enhance the iPhone and iPad services.

Request a Sample Report@ https://www.marketresearchfuture.com/sample_request/1086

Key Player
Google (U.S.)
Apple (U.S.)
Microsoft (U.S.)
Samsung (South Korea)
Adobe (U.S)
Fujitsu Limited (Japan)
Rossul (Canada)
Intel Corporation (U.S.)
ARM Ltd.(U.K.)
Oracle (U.S.)
LG Group (South Korea)

Segmentation:
Segmentation by Type: Mobile interface, Human-Machine interface, JQuery UI and Web-Service interface, among others.

Segmentation by Application: Education, Healthcare, Government, Market Intelligence, Retail and Consumer electronics among others.

Taste the market data and market information presented through more than 30 market data tables and figures spread over 110 numbers of pages of the project report. Avail the in-depth table of content TOC & market synopsis on “User Interface Services Market Research Report- Global Forecast to 2027”.

Browse Full Research Report @ https://www.marketresearchfuture.com/reports/user-interface-services-market

Objective of User Interface Services Market Study
To provide detailed analysis of the market structure along with forecast for the next 10 years of the various segments and sub segments of the Global User Interface Services market.
To provide insights about factors affecting the market growth.
To Analyze the User Interface Services Market based on various factors price analysis, supply chain analysis, porters five force analysis etc.
To provide historical and forecast revenue of the market segments and sub segments with respect to four main geographies and their countries North America, Europe, Asia, and Rest of the World (ROW).
To provide country level analysis of the market with respect to the current market size and future prospective.

TOC of User Interface Service Market

1 Market Introduction

2 Research Methodology

3 Market Dynamics

4 Executive Summary

5 Market Factor Analysis

6 Global User Interface Service Market by Application

7 Global User Interface Service Market by Type

7 Competitive Analysis

Continued……

About Market Research Future
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Info:
Name: Akash Anand
Organization: Market Research future
Address: Magarpatta Road, Hadapsar Pune – 411028
Phone: +1 646 845 9312

Source URL: http://marketersmedia.com/global-user-interface-services-market-industry-key-players-share-trend-applications-segment-and-forecast-to-2027/165420

For more information, please visit https://www.marketresearchfuture.com/reports/user-interface-services-market

Source: MarketersMedia

Release ID: 165420

Global Intravenous (IV) Iron and Oral Iron Market 2017 Share, Trend, Segmentation and Forecast to 2022

WiseGuyReports.Com Publish a New Market Research Report On – “Global Intravenous (IV) Iron and Oral Iron Market 2017 Share,Trend,Segmentation and Forecast to 2022”.

Pune, India – January 30, 2017 /MarketersMedia/

Global intravenous (IV) iron and oral iron market is expected to cross US$ 3 billion by 2021, growing at a CAGR of 5%.

Iron drugs are the supplements containing iron prescribed by a doctor to treat anemia or other iron deficiencies. Oral iron supplements are recommended to maintain the iron level in the body. However, in some cases, oral administrations are not capable of maintaining the iron level in the body and intravenous (IV) iron therapy comes into the picture.

Global Intravenous (IV) Iron and Oral Iron market research report covers the present scenario and the growth prospects of the iron drugs market for the period 2016-2021. The report provides in-depth market analysis of market size and growth of Global Intravenous (IV) Iron and Oral Iron market.

Download Sample Report @ https://www.wiseguyreports.com/sample-request/912467-global-intravenous-iv-iron-forecast-till-2021

For more information or any query mail at sales@wiseguyreports.com

Scope of the Report:

This market research report categories the Global Intravenous (IV) Iron and Oral Iron market based on mode of delivery, therapeutic area and geography. This market research includes a detailed market segmentation of the worldwide Intravenous (IV) iron and oral market by

By Mode of Delivery
• Oral Iron
• Ferrous Sulfate
• Carbonyl Iron
• Intravenous (IV) Iron
• Iron Dextran Complex
• Iron Sucrose
• Ferric Carboxymaltose

By Therapeutic Area
• Nephrology
• Gynecology and Obstetrics
• Gastroenterology
• Oncology
• Chronic Heart Failures
• Patient Blood Management

By Geography
• Americas
• APAC
• EMEA

By Country
• Africa
• Brazil
• Canada
• China
• France
• Germany
• India
• Italy
• Japan
• Mexico
• Netherland
• New Zealand
• Spain
• Switzerland
• UK
• US

Global Intravenous (IV) Iron and Oral Iron Market – Market Size and Dynamics
Analysts at Beige Market Intelligence expects the global intravenous (IV) iron and oral iron market to cross US$ 3 billion by 2021, growing at an impressive CAGR close to 5%. Iron drugs are widely used in various therapeutic areas like nephrology, gynaecology, oncology, gastroenterology, surgeries, and chronic heart failures. This catalyses the growth of global intravenous (IV) iron and oral iron market. Furthermore, factors such as correction of IDA in pregnancy, growing diabetic population worldwide, growing incidence of Chronic Kidney Disease (CKD) that increases the need of dialysis, prevalence of iron deficiency are the major factors attributing to the growth of the market.

The global intravenous (IV) iron and oral iron market is majorly categorised into two categories as per there mode of delivery such as oral and intravenous (IV). The oral delivery of iron in form of tablets, capsules, syrups is the most economic medical treatment for iron deficiency anaemia. Ferrous sulfate is the most common and cheapest form of oral therapy for treating patients with iron deficiency anemia. Though oral iron drugs market size is expected to increase to a notable figure over next five years, it can lose significant amount of its market share to intravenous (IV) iron therapies in near future.

Intravenously iron is delivered to patients who are either unable to absorb oral iron or who has increasing anemia despite adequate doses of oral iron. Growing incidence of Chronic Kidney Disease (CKD), iron deficiency diseases related to gynecology, nephrology, gastroenterology, and oncology is driving growth of the intravenous iron therapy. The high growth rate of IV iron market can be attributed to the paradigm shift of healthcare providers/patients to IV iron therapies from oral iron therapies.

The research report provides a detailed analysis and growth forecast of each therapeutic area. Nephrology is the largest application area of the intravenous (IV) iron and oral iron drugs followed by Gynecology and Gastroenterology.

Global Intravenous (IV) Iron and Oral Iron – Trends, Drivers, and Challenges
The market research report on intravenous (IV) iron and oral iron market provides a comprehensive study about the factors affecting the market growth and upcoming challenges. The research report describes the growth driving factors of the global intravenous (IV) iron and oral iron market for the next five years. Increasing number of dialysis patients and growing diabetic population worldwide are among the major drivers described in the intravenous (IV) iron and oral iron market research report.

Paradigm shift from oral iron drugs to intravenous (IV) iron drugs is a major trend in the market. There are gastrointestinal side effects associated with oral iron drugs like nausea, constipation, anorexia, heartburn, vomiting, and diarrhea and are intolerant even by healthy patients. Thus the side effects of oral iron drugs has attracted the patients towards intravenous (IV) iron. Also with the increasing awareness of IDA during pregnancy and shift towards healthier lifestyle; correction of IDA in pregnant women is the current trend driving the market for oral and IV iron.

…………..

The report also provides the Porter’s five forces analysis along with a description of each of the forces and its impact on the market.

Complete Report Details @ https://www.wiseguyreports.com/reports/912467-global-intravenous-iv-iron-forecast-till-2021

Global Intravenous (IV) Iron and Oral Iron – Geographical Analysis

The report includes the market analysis of global intravenous (IV) iron and oral iron market in different regions such as the Americas, APAC, and EMEA. The report outlines the major market share holder in the global intravenous (IV) iron and oral iron market and the market size analysis of all the regions. The intravenous (IV) iron and oral iron market report also provides the market size and forecast of the key countries. The America region is expected to be the largest market for intravenous (IV) iron and oral iron drugs followed by EMEA. US, Canada, and Brazil are the key countries in this region contributing a major chunk of revenue.

………..CONTINUED

For more information or any query mail at sales@wiseguyreports.com

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=912467

Contact Info:
Name: Norah Trent
Email: sales@wiseguyreports.com
Organization: WiseGuy Research Consultants Pvt Ltd.
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar Pune – 411028
Phone: +1-646-845-9349

Source URL: http://marketersmedia.com/global-intravenous-iv-iron-and-oral-iron-market-2017-share-trend-segmentation-and-forecast-to-2022/165367

For more information, please visit https://www.wiseguyreports.com

Source: MarketersMedia

Release ID: 165367

Pharma-Bio Serv Announces Results for the Year Ended October 31, 2016

DORADO, PUERTO RICO / ACCESSWIRE / January 30, 2017 / Pharma-Bio Serv, Inc. (Pharma-Bio Serv or the Company) (OTCQB: PBSV), a compliance, project management and technology transfer support consulting firm, that provides services to the pharmaceutical, biotechnology, chemical, medical device, cosmetic, food and allied products industries, today announced net revenues for the year ended October 31, 2016 were $19.5 million, a decrease of approximately $3.8 million, or 16%, when compared to last year.

The revenue decrease is mainly attributable to a decline of $2.9 million in the Puerto Rico consulting market, of which $1.3 million is attributable to projects in Latin America which were managed from Puerto Rico, plus $1.2 million and $0.3 million decrease in the United States and Europe consulting markets, respectively, partially offset by a gain in the Puerto Rico Lab and project revenue from the Brazil consulting market of approximately $0.4 million and $0.2 million, respectively. Other Company divisions sustained minor revenue gains/losses or remained constant, when compared to last year.

For the year ended October 31, 2016, the Company reported a net loss of approximately $0.3 million, a decrease in earnings of $1.9 million when compared to the same period last year. The variance is mainly attributable to the decline in revenue, continued investment on business development and operational support expenses, recorded other than temporary impairment on available for sale securities, the recording of the early lease cancellation fee for our Pennsylvania office facilities, and the effect of the effective income tax rates (including Puerto Rico favorable tax grants) over income before tax.

“Throughout 2016, we have continued our strategic re-alignment and investment in resources and infrastructure designed to achieve profitability on our non-performing operations, over the long term. We have focused on consulting business development in existing and new markets, expansion of our Puerto Rico Lab facilities, development of a new Lab facility in Spain, and enhancing our Calibrations division facility in Puerto Rico,” said Victor Sanchez, CEO of Pharma-Bio Serv. “Our investment in our consulting team, new markets and services, Lab facilities and equipment during fiscal year 2016 provides a stronger foundation upon which sustainable growth for the Company can be realized in future years,” he added.

About Pharma-Bio Serv, Inc.

Pharma-Bio Serv is a compliance, project management and technology transfer support consulting firm, headquartered in Puerto Rico, with operations in the U.S., Ireland, and Spain. Pharma-Bio Serv’s core business is FDA and other international regulatory compliance agency related services, with integrated portfolio services including microbiological and chemical testing services for clients in the Pharmaceutical, Biotechnology, Chemical, Medical Device, Cosmetic, Food and Allied Products industries. The Company’s services also include “Pharma Serv Academy,” a division that provides technical and regulatory standards seminars/training conducted by industry experts. The Company’s global team includes leading engineering and life science professionals, quality assurance managers and directors.

Forward Looking Statements

This news release contains “forward-looking statements” within the meaning of the U.S. federal securities laws, which statements may include information regarding the plans, intentions, expectations, future financial performance, or future operating performance of Pharma-Bio Serv. Forward-looking statements are based on the expectations, estimates, or projections of management as of the date of this news release. Although Pharma-Bio Serv’s management believes these expectations, estimates, or projections to be reasonable as of the date of this news release, forward-looking statements are inherently subject to significant business risks, economic and competitive uncertainties, or other contingencies, which could cause its actual results or performance to differ materially from what may be expressed or implied in the forward-looking statements. There can be no assurance that the processes being undertaken by Pharma-Bio Serv will result in growth through business development or mergers and acquisitions. Important factors that could cause Pharma-Bio Serv’s actual results or performance to differ materially from the forward-looking statements include those set forth in the “Risk Factors” section of Pharma-Bio Serv’s Annual Report on Form 10-K for the year ended October 31, 2015, and in its other filings with the Securities and Exchange Commission, which filings are available on www.sec.gov. Pharma-Bio Serv disclaims any intention or obligation to update or revise any forward-looking statements to reflect subsequent events and circumstances, except to the extent required by applicable law.

Investor Relations Contact:

Scott Gordon
President
CorProminence LLC
scottg@corprominence.com
631 703 4900

SOURCE: Pharma-Bio Serv

ReleaseID: 453856

Gingivitis Pharmaceutical, Drug and Healthcare Pipeline Review H2

WiseGuyReports.com adds “Gingivitis Global Clinical Trials Review, H2, 2016” reports to its database.

Pune, India – January 30, 2017 /MarketersMedia/

Summary
“Gingivitis Global Clinical Trials Review, H2, 2016″ provides an overview of Gingivitis clinical trials scenario. This report provides top line data relating to the clinical trials on Gingivitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Clinical Trial Reports are generated using proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/910172-gingivitis-global-clinical-trials-review-h2-2016

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Scope
– The report provides a snapshot of the global clinical trials landscape
– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
– The Report provides enrollment trends for the past five years
– Report provides latest news for the past three months

Reasons to buy
– Assists in formulating key business strategies with regards to investment
– Helps in identifying prominent locations for conducting clinical trials which saves time and cost
– Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
– Supports understanding of trials count and enrollment trends by country in global therapeutics market
– Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
– Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Content: Key Points
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Gingivitis to Mouth and Dental Disorders Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Gingivitis to Mouth and Dental Disorders Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Gingivitis Therapeutics Clinical Trials 27
Prominent Drugs 29
Clinical Trial Profile Snapshots 30
…Continued

ACCESS REPORT @ https://www.wiseguyreports.com/reports/910172-gingivitis-global-clinical-trials-review-h2-2016

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Contact Info:
Name: Norah Trent
Organization: WiseGuy Reports
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar Pune – 411028 Maharashtra, India
Phone: +1-646-845-9349

Source URL: http://marketersmedia.com/gingivitis-pharmaceutical-drug-and-healthcare-pipeline-review-h2/165374

For more information, please visit http://www.wiseguyreports.com

Source: MarketersMedia

Release ID: 165374

IOT-Identity Access Management Market is expected to grow at CAGR of 16% and USD 20 billion by 2022

IOT- Identity Access Management Market is expected to grow at CAGR of 16% and expected to reach market size of USD 20 Billion by the end of forecast period | IOT- Identity Access Management Market

Pune, India – January 30, 2017 /MarketersMedia/

Market Highlights
IOT- Identity Access Management Market is expected to grow at CAGR of 16% and expected to reach market size of USD 20 Billion by the end of forecast period. IOT- identity access management market is expected to grow owing to the increasing investment by companies on information technology to streamline their operations and gain efficiency. The Global Identity and Access Management Market (IAM) have shown a robust growth owing to the increased needs of businesses to be guarded not only against unauthorized third-party access into their information systems, but also malicious insiders. High adoption of IT is increasing data breaches, leakage of critical intellectual property, denial-of-service (DOS) attacks and vulnerability to cyber-attacks, from within and outside the organization which is challenging the market to grow in the forecast period.

Request a Sample Report@ https://www.marketresearchfuture.com/sample_request/2034

Segmentation:
The Global IOT- Identity Access Management Market has been segmented on the basis of services, deployment, customer type and industry. Services comprises of user provisioning, multi-factor authentication, directory services, password management, access management and single-sign-on (SSO) among others. Deployment comprises of on-cloud, on-premise and hybrid. Industry includes small and medium enterprises (SME’s) and large enterprises among others. End-user can be segmented on basis of IT & telecom, government, energy & utility services, education, retail & e-commerce, banking & financial services, media & entertainment and manufacturing among others.

Key Player
IBM Corporation (U.S.)
Microsoft Corporation (U.S.)
Hitachi, Ltd. (Japan)
EMC Corporation (U.S.)
Intel Security Group (U.S.)
Siemens AG (Germany)
Oracle Corporation (U.S.)
ARCON Tech Solutions (India)
Cloud Security Alliance (U.S.)
CA Technologies (U.S.)

Regional Analysis
The regional analysis of IOT- identity access management market is being studied for areas such as Asia pacific, North America, Europe and rest of the world. North America is expected to dominate the IOT- identity access management market owing to rapid adoption of cloud applications and mobile applications in the region. In the North American region, many federal government organizations are emphasizing on use of personal identification card for accessing government IT infrastructure which is also fueling the IoT-identity access management market in the region. Europe is projected to grow owing to the establishment of policies by government cyber authorities to protect confidential data.

Taste the market data and market information presented through more than 30 market data tables and figures spread over 100 numbers of pages of the project report. Avail the in-depth table of content TOC & market synopsis on “The Global IOT- Identity Access Management Market Research Report -Forecast to 2022”.

Browse Full Research Report @ https://www.marketresearchfuture.com/reports/iot-identity-access-management-market

TOC of IOT Identity Access Management Market
1 Market Introduction

2 Research Methodology

3 Market Dynamics

4 Executive Summary

5 Market Factor Analysis

6 Global IOT Identity Access Management Market, By Segments

7 Competitive Analysis

Continued……

About Market Research Future
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Info:
Name: Akash Anand
Organization: Market Research future
Address: Magarpatta Road, Hadapsar Pune – 411028
Phone: +1 646 845 9312

Source URL: http://marketersmedia.com/iot-identity-access-management-market-is-expected-to-grow-at-cagr-of-16-and-usd-20-billion-by-2022/165378

For more information, please visit https://www.marketresearchfuture.com/reports/iot-identity-access-management-market

Source: MarketersMedia

Release ID: 165378

Bronchiectasis Pharmaceutical and Healthcare Pipeline Review H2

WiseGuyReports.com adds “Bronchiectasis Global Clinical Trials Review, H2, 2016” reports to its database.

Pune, India – January 30, 2017 /MarketersMedia/

Summary

“Bronchiectasis Global Clinical Trials Review, H2, 2016″ provides an overview of Bronchiectasis clinical trials scenario. This report provides top line data relating to the clinical trials on Bronchiectasis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Clinical Trial Reports are generated using proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/910176-bronchiectasis-global-clinical-trials-review-h2-2016

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Scope
– The report provides a snapshot of the global clinical trials landscape
– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
– The Report provides enrollment trends for the past five years
– Report provides latest news for the past three months

Reasons to buy
– Assists in formulating key business strategies with regards to investment
– Helps in identifying prominent locations for conducting clinical trials which saves time and cost
– Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
– Supports understanding of trials count and enrollment trends by country in global therapeutics market
– Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
– Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Content: Key Points
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Bronchiectasis to Respiratory Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Bronchiectasis to Respiratory Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Bronchiectasis Therapeutics Clinical Trials 27
Prominent Drugs 28
Latest Clinical Trials News on Bronchiectasis 29
…Continued

ACCESS REPORT @ https://www.wiseguyreports.com/reports/910176-bronchiectasis-global-clinical-trials-review-h2-2016

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Contact Info:
Name: Norah Trent
Email: sales@wiseguyreports.com
Organization: WiseGuy Reports
Address: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar Pune – 411028 Maharashtra, India
Phone: +1-646-845-9349

Source URL: http://marketersmedia.com/bronchiectasis-pharmaceutical-and-healthcare-pipeline-review-h2/165380

For more information, please visit http://www.wiseguyreports.com

Source: MarketersMedia

Release ID: 165380

New Customer Of The Month Award Announced For SmoothRx Scar Removal Cream

In an effort to give back to their customers, SmoothRx announced today that they would give out a customer of the month award.

New Customer Of The Month Award Announced For SmoothRx Scar Removal Cream

Miami, FL, United States – January 30, 2017 /PressCable/

Grateful for their loyal customers who have helped to make their scar removal cream the top-rated scar treatment cream on Amazon.com, SmoothRx announced this week that they wanted to give something back to their customers by way of a customer appreciation day. Company spokesperson Ashley Royal explained the program.

“Our customers have been loyal, enthusiastic and the reason our scar removal cream is a best-seller,” offered Royal. “We love to hear stories about how our scar removal cream has helped to fade the scars and stretch marks for our customers and helped give them the hope and confidence they needed in their appearance. Now we want to take things a step further, and celebrate their dedication to our scar removal cream by reviewing their photos and stories, and declaring one customer each month the SmoothRx customer of the month.” Customers are encouraged to continue to share their photos on experiences on various social media sites, tagging SmoothRx in their post. Company representatives will use these tags to find and review customers postings, then announce the customer of the month.

The SmoothRx scar removal cream is an all-natural cream filled with only the highest-quality ingredients. Some of these ingredients include organic olive oil, shea butter, cocoa butter, grapefruit seed oil, aloe, mango butter and rose hip seed oil. The moisturizing properties of this cream help to improve the elasticity of the skin of the customers, which can not only help fade current scars and stretch marks but also help prevent new scars or stretch marks from forming.

The SmoothRx scar removal cream currently has over 160 customers reviews on their Amazon.com listing. A recent verified purchase customer wrote a five-star review and said “Unfortunately, I didn’t think to do a before picture. This stuff is truly amazing!! I really didn’t expect to find anything to help my scars ever after all the products I’ve gone through, but this has worked amazingly! Every few days I see a MAJOR change!! Thanks so much!”

SmoothRx scar cream is sold exclusively on Amazon.com and is now priced at $19.95. Amazon.com offers free shipping on any combined purchase of $49 or more.

About SmoothRx: “SmoothRx makes premium scar creams for stretch mark removal, acne scar removal, fine line removal, spider vein removal, and general scar removal. Made in the United States, we only use premium natural ingredients such as orange oil, grapefruit seed extract, shea butter, cocoa butter, and more. We sell primarily on amazon.com and hope to improve the lives of those who are troubled with scars and other cosmetic hindrances.”

Contact Info:
Name: Ashley Royal
Email: orders@smoothrx.com
Organization: SmoothRx
Address: 123 S.E. 3rd Ave #427, Miami, FL, 33131 United States
Phone: +1-469-233-5857

For more information, please visit https://www.amazon.com/Best-Scar-Cream-Stretch-Removal/dp/B00RSN5N8G

Source: PressCable

Release ID: 165440

Drone Aerial Filming Company Light Colour Sound Launches New Website

Light Colour Sound this week announces the launch of its new responsive website showcasing its drone aerial video, cinematography and photography work.

Drone Aerial Filming Company Light Colour Sound Launches New Website

Newquay, United Kingdom – January 30, 2017 /PressCable/

Drone aerial filming and cinematography specialist Light Colour Sound has this week launched a new website to showcase its drone and film production work.

The new website includes information on the full range of aerial filming and video production services the company offers, as well as video clips showcasing its professional client work.

The Cornwall based company provides aerial filming services for companies all over the UK and overseas. Its client list includes Red Bull, the National Trust, the BBC and National Geographic, taking its creative cinematographers all over the world for professional TV, film and video shoots.

Light Colour Sound’s work takes its operatives to some spectacular locations, from the cliffs of Cornwall to the glaciers of Iceland. The team of adventure sports enthusiasts are always up for a challenge and use their skills and experience to get the perfect footage, sometimes in remote locations under extreme conditions.

What’s more, the team at Light Colour Sound are BBC approved drone operators due to their recent work on a well known drama series. To achieve this status, the company had to have all of its drones, safety processes and operational procedures audited by the BBC accredited suppliers team.

Company spokesperson and drone pilot James Keith commented: “Obtaining this approval only goes to strengthen our image as a drone team that not only provides the highest quality aerial filming, but we do it safely.”

The new website was designed and developed in-house by the company’s talented creatives, meaning they had full control over the style and content of the site. It utilises the latest standards of responsive design, offering great performance across different devices, from desktop to tablets to mobile phone.

James Keith commented: “It was important for us to have a professional looking website that also represented our unique identity and creativity. We’re really pleased with the result and look forward to hearing comments from our prospective clients.”

For more information, visit http://lightcoloursound.co.uk/

Contact Info:
Name: James Keith
Organization: Light Colour Sound
Address: High Street, Newquay, TR7 2TW United Kingdom
Phone: +44-7983-706452

For more information, please visit http://lightcoloursound.co.uk/

Source: PressCable

Release ID: 165430

Maple Leaf Short Duration 2017 Flow-Through Limited Partnership – National & Quebec Class

Final Prospectus Filed. Books Closing on February 16, 2017 for Initial Closing

VANCOUVER, BC / ACCESSWIRE / January 30, 2017 / Maple Leaf Short Duration 2017 Flow-Through Limited Partnership (the “Partnership”) is pleased to announce that it has filed a final prospectus (the “Prospectus”) dated January 27, 2017 with the securities commissions or similar authorities in each of the Provinces and Territories of Canada relating to the initial public offering of units of the Partnership. The maximum offering of the Partnership’s National Class Units is $15,000,000 and the Québec Class Units is $10,000,000. The books will close on Thursday, February 16, 2017 at 12 noon (EST) for its initial closing on February 17, 2017.

Partnership Objectives & Benefits – National Class Units

The Partnership is designed to provide holders of National Class Units (“National Class Limited Partners”) with an investment in a diversified portfolio of Flow-Through Shares of Resource Companies incurring Eligible Expenditures (as those terms are defined in the Prospectus) across Canada with a view to maximizing the tax benefits of an investment in National Class Units and achieving capital appreciation and/or income for National Class Limited Partners. National Class Limited Partners must be residents of Canada or liable to pay Canadian income tax.

Investors are expected to receive tax deductions for 2017 of approximately 100% of the amount invested based on and subject to certain conditions as set forth in the Prospectus.

Partnership Objectives & Benefits – Québec Class Units

The Partnership is designed to provide holders of Québec Class Units (“Québec Class Limited Partners”) with an investment in a diversified portfolio of Flow-Through Shares of Resource Companies incurring Eligible Expenditures principally in the Province of Québec with a view to maximizing the tax benefits of an investment in Québec Class Units and achieving capital appreciation and/or income for Québec Class Limited Partners. Québec Class Units are most suitable for investors who reside in the Province Québec or are liable to pay income tax in Québec.

Investors are expected to receive tax deductions for 2017 of up to 130% of the amount invested based on and subject to certain conditions as set forth in the Prospectus.

Liquidity Event

The investment portfolios of both the National and Québec Class Units will be actively managed in such a way as to preserve the ability to undertake a future liquidity event, such as a rollover into a mutual fund corporation.

The Syndicate

The syndicate of agents for the offering is being led by Scotiabank, BMO Capital Markets, CIBC, and National Bank Financial Inc. and includes Canaccord Genuity Corp., Desjardins Securities Inc., Manulife Securities Incorporated, Raymond James Ltd., Industrial Alliance Securities Inc., Laurentian Bank Securities Inc., and Echelon Wealth Partners Inc.

A copy of the Prospectus can be obtained from any agent.

Offering Jurisdictions

Each of the Provinces and Territories of Canada.

FOR FURTHER INFORMATION, PLEASE CONTACT

Hugh Cartwright, Chairman
MAPLE LEAF FLOW-THROUGH PROGRAMS
Tel: 1-866-688-5750 Email: info@mapleleaffunds.ca
Web: www.MapleLeafFunds.ca

SOURCE: Maple Leaf Short Duration 2016-II Flow-Through Limited Partnership

ReleaseID: 453864